Arie Belldegrun - 31 Mar 2026 SCHEDULE 13G/A Report for Allogene Therapeutics, Inc. Common Stock (ALLO)

Filing Manager
Arie Belldegrun
Reporting Manager
Arie Belldegrun, M.D.
Symbol
ALLO
Shares outstanding
249,377,463 shares
Disclosed Ownership
13,466,383 shares
Ownership
5.4%
Form type
SCHEDULE 13G/A
Filing time
13 May 2026, 19:11:51 UTC
Date of event
31 Mar 2026
Previous filing
17 Feb 2026

Quoteable Key Fact

"Arie Belldegrun disclosed 5.4% ownership in Allogene Therapeutics, Inc. Common Stock (ALLO) on 31 Mar 2026."

Quick Takeaways

  • Arie Belldegrun filed SCHEDULE 13G/A for Allogene Therapeutics, Inc. Common Stock (ALLO).
  • Disclosed ownership: 5.4%.
  • Date of event: 31 Mar 2026.

What Changed

  • Previous schedule filing date: 17 Feb 2026.
  • Current filing was accepted on 13 May 2026, 19:11.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Arie Belldegrun, M.D. 5.4% 13,466,383 4,694,096 8,772,287 /s/ Arie Belldegrun Arie Belldegrun, M.D.
Bellco Legacy LLC 0.2% 539,867 0 539,867 /s/ Arie Belldegrun By Arie Belldegrun, M.D., Manager
Bellco Legacy IV LLC 1.9% 4,710,120 0 4,710,120 /s/ Arie Belldegrun By Arie Belldegrun, M.D., Manager
Vida Ventures LLC 0.7% 1,798,163 0 1,798,163 /s/ Arie Belldegrun By VV Manager LLC, its Manager, By Arie Belldegrun, M.D., Senior Managing Director
Vida Ventures III, L.P. 0.7% 1,720,172 0 1,720,172 /s/ Arie Belldegrun By Vida Ventures GP III, LLC, its Manager, By Arie Belldegrun, M.D., Senior Managing Director
Vida Ventures III-A, L.P. 0% 3,965 0 3,965 /s/ Arie Belldegrun By Vida Ventures GP III, LLC, its Manager, By Arie Belldegrun, M.D., Senior Managing Director,
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .